Jinhwa Lee,Suk Ho Lee,Hee Jeong Seo,Min Ju Kim,Suk Youn Kang,Jeongmin Kim,Sung-Han Lee,Myung Eun Jung,Eun Jung Son,Kwang-Seop Song,Mi-Soon Kim
申请号：
US13379301
公开号：
US20120101051A1
申请日:
2010.06.18
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A novel C-aryl glucoside compound, or a pharmaceutically acceptable salt or a prodrug thereof having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly, diabetes, are provided.
